About
Cortex, Inc. is a medical technology company that specializes in advanced diagnostic mapping solutions for atrial fibrillation (AF), a heart rhythm disorder affecting millions globally. The company is known for its flagship product, the OptiMap™ System, which utilizes a basket-shaped catheter with 64 electrodes to capture detailed electrical activity in the heart. A proprietary algorithm analyzes these signals in real time, helping physicians identify active AF sources and develop targeted ablation strategies. The OptiMap System received FDA 510(k) clearance in 2023 and has shown promising clinical results, including a significant improvement in AF-free outcomes compared to traditional methods. Cortex's primary customers are electrophysiologists and cardiologists who perform cardiac ablation procedures. The company has attracted substantial investment and is set to enhance Boston Scientific’s electrophysiology portfolio, making its innovative solutions more accessible to healthcare providers and patients worldwide.
Technologies
Keywords
Company Information
- Employees22
- Founded2023
- Annual Revenue$5500000
- Total Funding$153499998
Location
3350 Scott Boulevard, Santa Clara, California, United States, 95054
